Related Experiment Video

Updated: Aug 18, 2026

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans
11:07

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans

Published on: December 19, 2014

Cryptococcal meningitis

Tihana Bicanic1, Thomas S Harrison

  • 1Division of Infectious Diseases, Department of Cellular and Molecular Medicine, St. George's Hospital Medical School, London, UK.

British Medical Bulletin
|April 20, 2005
PubMed

Insights

Cryptococcal meningitis in AIDS patients has high mortality due to limited antifungal drugs and increased intracranial pressure. Improved treatments and antiretroviral therapy are crucial for better outcomes in these opportunistic infections.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Immunology

Background:

  • Cryptococcal meningitis is a significant opportunistic infection in individuals with Acquired Immunodeficiency Syndrome (AIDS).
  • High mortality rates persist despite current treatments, particularly in regions with a high prevalence of HIV/AIDS.
  • Raised intracranial pressure is a major complication exacerbating mortality in HIV-associated cryptococcal meningitis.

Purpose of the Study:

  • To review the current understanding of cryptococcal meningitis in HIV-infected individuals.
  • To discuss the challenges and limitations of existing therapeutic strategies.
  • To highlight areas for future research and treatment improvement.

Main Methods:

  • Literature review of cryptococcal meningitis in immunocompromised patients.
  • Analysis of current treatment guidelines and their efficacy.
  • Discussion of complications and management strategies.

Main Results:

  • Mortality from HIV-associated cryptococcal meningitis remains high (10-30%) due to drug limitations and intracranial pressure.
  • Optimal therapy involves amphotericin B and flucytosine, followed by fluconazole, with supportive measures like saline loading and CSF drainage.
  • Antiretroviral therapy expansion offers hope for long-term prognosis if the acute phase is managed successfully.

Conclusions:

  • There is a critical need for more effective antifungal drug regimens.
  • Improved management of raised intracranial pressure is essential for reducing mortality.
  • Advancements in antiretroviral programs, coupled with optimized meningitis treatment, can transform patient outcomes.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...